Evaluation of coverage, compliance of mass drug administration and assessment of awareness about lymphatic filariasis in Tikamgarh district of Madhya Pradesh: a cross sectional study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20190618Keywords:
Coverage, Compliance, Mass drug administration, Lymphatic filariasisAbstract
Background: Lymphatic filariasis is the second leading cause of disability worldwide accounting for more than 5 million disability adjusted life years annually. It has been a major public health problem in India which leads to irreversible chronic manifestations which are responsible for considerable economic loss and severe physical disability to the affected individuals. Mass drug administration (MDA) means administration of diethylcarbamazine and albendazole tablets to all people (excluding children <2 years, pregnant women, seriously ill persons) in endemic areas once in a year. The objective of the study was to assess coverage, compliance of MDA and awareness about lymphatic filariasis in Tikamgarh district of Madhya Pradesh.
Methods: Cross-sectional study was conducted and total 120 households were surveyed in four randomly selected clusters of Tikamgarh district of Madhya Pradesh.
Results: Out of total 743 persons 678 (91.25%) persons were eligible for MDA. Coverage rate was 86.57% and compliance rate was 74.27%. The main reason for non-compliance was not having the concerned disease (55.78%) followed by fear of side effect (22.31%). Only 40.83% among the surveyed families were aware about MDA and only 45.83% respondents had heard about lymphatic filariasis.
Conclusions: There is coverage and compliance gap and awareness about the lymphatic filariasis and MDA program is limited. Drug compliance need to be improved and awareness need to be raised. MDA program should not be confined to tablet distribution only and due importance should be given to compliance rate.
References
Sundarlal. Text Book of Community Medicine, Preventive and Social Medicine. 4th Edition. CBS Publishers Distributors Pvt Ltd; 2018: 476-477.
Suryakantha AH. Community Medicine with Recent Advances. 3rd Ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2014: 429.
Biradar M, Holyachi S. Coverage and compliance of mass drug administration against lymphatic filariasis in Kalaburgi district. Int J Community Med Public Health. 2017;4(7):2502-5.
Mahajan, Gupta. Textbook of preventive and social medicine. 4th Edition. New Delhi: Jaypee Brothers medical publishers (P) Ltd; 2013; 319.
Park’s textbook of Preventive and Social Medicine, 23rd Edition. Jabalpur: M/s Banarsidas Bhanhot Publishers; 2015: 270.
J Kishore’s National health programs of India, 11th Edition. New Delhi: Century Publications; 2011: 390.
Lahariya C, Mishra A. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study. J Vector Borne Disease. 2008;45:313-20.
Anil NS. Assessing Coverage of Mass Drug Administration against Lymphatic Filariasis in Gulbarga District, Karnataka. Int J Med Public Health. 2012;2(3):25-8.
Godale L, Ukarande B .A study on coverage evaluation, compliance and awareness of mass drug administration for elimination of lymphatic filariasis in Osmanabad district. National J Community Med. 2012;3(3):391-4.
Havale N. Evaluation of coverage and compliance of elimination of lymphatic filariasis by mass drug administration campaign in Gulbarga and Yadgiri districts of Karnataka state. Int J Res Medical Sci. 2015;3(8):2105-8.
Satapathy D, Pradhan S, Acharya H, Nayak U, Agrawal S, Naik G. Rural and Urban Differences in MDA Coverage for Filariasis in Jharsuguda District of Odisha. Int J Med Res Prof. 2016;2(5):70-4.
Prasad P, Arya R, Bansal M, Singh S. Mid-term assessment of mass drug Administration of DEC for filariasis in Rewa and chhindwara districts of Madhya Pradesh. National J Community Med. 2013;4(3):520-4.
Mehta S, Shah V, Verma A, Patel N, Bansal R. Comparison of coverage and compliance of mass drug administration 2012 in surat, India. National J Community Med. 2012;3(3):448-72.
Jothula KY, Naidu NK, Malhotra V, Prasad VG, Kabra PR, Nagaraj K. Evaluation of mass drug administration programme for elimination of lymphatic filariasis in Nalgonda district, Telangana, India. Int J Community Med Public Health. 2016;3(8):2008-12.
Gupta A. Evaluation of mass drug administration for elimination of lymphatic filariasis in Panna district of Madhya Pradesh. Paripex Indian J Res. 2015;4(5):269-71.
Kulkarni M, Veena K, Sujatha K, Darshan B, Varun N, Asha. Coverage & Compliance of mass drug administration program against filariasis in Bijapur district, Karnataka. J Pub Health Med Res. 2013;1(1):9-12.
Nirgude A, Naik P, Nagaraj K, Sidramappa R, Takalkar A, Prasad V. Evaluation of coverage and compliance of Mass drug administration programme 2011 for Elimination of lymphatic filariasis in Nalgonda district of Andhra Pradesh, India. National J Community Med. 2012;3(2):288-93.
Karmakar P, Mitra K, Chatterjee A, Jana P, Bhattacharya S, Lahiri K. A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India. J Vector Borne Dis. 2011;48:101–4.
